[1]刘朝阳,张善革.二甲双胍单药及不同联合用药方案治疗2型糖尿病的随机对照研究[J].医学信息,2019,32(04):148-150.[doi:10.3969/j.issn.1006-1959.2019.04.048]
　LIU Chao-yang,ZHANG Shan-ge.A Randomized Controlled Trial of Metformin Monotherapy and Different Combination Regimens in the Treatment of Type 2 Diabetes[J].Journal of Medical Information,2019,32(04):148-150.[doi:10.3969/j.issn.1006-1959.2019.04.048]
点击复制

二甲双胍单药及不同联合用药方案治疗2型糖尿病的随机对照研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年04期
页码:
148-150
栏目:
药物与临床
出版日期:
2019-02-15

文章信息/Info

Title:
A Randomized Controlled Trial of Metformin Monotherapy and Different Combination Regimens in the Treatment of Type 2 Diabetes
文章编号:
1006-1959（2019）04-0148-03
作者:
刘朝阳1; 2; 张善革2
（1.天津市中医药研究所附属医院，天津 300000；2.天津市大王庄街社区卫生服务中心，天津 300000）
Author(s):
LIU Chao-yang1; 2; ZHANG Shan-ge2
(1.Affiliated Hospital of Tianjin Institute of Traditional Chinese Medicine,Tianjin 300000,China;2.Tianjin Dawangzhuang Street Community Health Service Center,Tianjin 300000,China)
关键词:
二甲双胍; 联合用药; 2型糖尿病
Keywords:
Metformin; Combination therapy; Type 2 diabetes
分类号:
R587.1
DOI:
10.3969/j.issn.1006-1959.2019.04.048
文献标志码:
A
摘要:
目的 观察二甲双胍单药及不同联合用药方案治疗2型糖尿病的临床疗效。方法 回顾分析2017年1月~2018年6月在我院接受治疗的108例2型糖尿病患者临床资料，依据治疗方案分为A、B、C组，各36例，A组采用二甲双胍单药治疗，B组采用二甲双胍联合格列吡嗪缓释片治疗，C组采用二甲双胍联合沙格列汀治疗，比较3组治疗总有效率，记录患者空腹血糖（FPG）、餐后2h血糖（2 hPG）、糖化血红蛋白（HbA1c）水平及低血糖发生情况。结果 A组治疗总有效率为97.22%、B组为94.44%、C组为94.44%，差异无统计学意义（P＞0.05）；治疗后3组FPG、2 hPG、HbA1c水平均下降，与治疗前比较差异有统计学意义（P＜0.05），C组FPG、2 hPG水平以及B组FPG水平改善均优于A组，差异有统计学意义（P＜0.05），B、C组间各指标对比，差异无统计学意义（P＞0.05）； A、C组夜间均未发生低血糖，B组发生4例低血糖，发生率为11.11%，C组肝肾功能异常3例，发生率为8.33%。结论 二甲双胍单药及不同联合用药方案治疗2型糖尿病均能获得较好的疗效，但联合用药可以发挥协同作用，更好的控制血糖水平，临床可依据患者具体情况选择治疗方案。
Abstract:
Objective To observe the clinical efficacy of metformin monotherapy and different combination regimens in the treatment of type 2 diabetes. Methods The clinical data of 108 patients with type 2 diabetes who were treated in our hospital from January 2017 to June 2018 were retrospectively analyzed. According to the treatment plan, they were divided into groups A, B and C, 36 cases in each group. Group A was treated with metformin monotherapy. Group B was treated with metformin combined with glipizide sustained-release tablets. Group C was treated with metformin combined with saxagliptin. The fasting blood glucose (FPG), postprandial 2 h blood glucose (2 hPG), glycosylated hemoglobin (HbA1c) levels were recorded. The incidence of hypoglycemia was compared and the total effective rate of the three groups was compared. Results The total effective rate was 97.22% in group A, 94.44% in group B and 94.44% in group C,the difference was not statistically significant (P>0.05). After treatment, the levels of FPG, 2 hPG and HbA1c decreased,there was significant difference between the two groups (P<0.05). The FPG, 2 hPG level and B group FPG level in group C were better than those in group A, the difference was statistically significant (P<0.05).There was no significant difference in the indexes between groups B and C (P>0.05). There was no hypoglycemia in group A and group C, and 4 cases of hypoglycemia occurred in group B, the incidence rate was 11.11%. Group C liver and kidney function There were 3 abnormalities, the incidence rate was 8.33%. Conclusion Metformin monotherapy and different combination regimens can achieve better curative effect on type 2 diabetes, but the combination can play a synergistic role to better control blood sugar levels. The clinical choice can be based on the patient's specific conditions.

参考文献/References:


[1]姚璐,田国祥,武云涛,等.二甲双胍分别联合利拉鲁肽及甘精胰岛素治疗2 型糖尿病的临床观察[J].中国询证心血管医学杂志,2015,7(17):100-102.
[2]谭敏琪.治疗2型糖尿病患者摄取治疗中应用二甲双胍的效果分析[J].今日药学,2015,8(3):40-41.
[3]吴曼,马建丽,王喆,等.那格列奈联合二甲双胍治疗2型糖尿病疗效和安全型的系统评价[J].中国药物应用与监制,2015,12(1):5-8.
[4]邓清义.二甲双胍治疗老年糖尿病患者的疗效观察[J].中国国现代药物应用,2014,8(10):23-24.
[5]田少雄,陈均忠.二甲双胍不同联合用药方案治疗2 型糖尿病的成本-效果分析[J].海峡药学,2014,25(11):194-196.
[6]于海英,刘畅,王福青,等.两种联合用药方案治疗2 型糖尿病的疗效[J].中国老年学杂志,2011,31(15):2864-2865.
[7]黄依,尤志华,裴泂,等.二甲双胍单药及不同联合用药方案治疗2 型糖尿病的随机对照研究[J].实用临床医药杂志,2013,17(17):87-88.

相似文献/References:

[1]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
　XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Journal of Medical Information,2022,35(04):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[2]范卢明,王 慧,薛 帆,等.缬沙坦联合二甲双胍治疗肥胖型高血压效果的Meta分析[J].医学信息,2022,35(15):68.[doi:10.3969/j.issn.1006-1959.2022.15.014]
　FAN Lu-ming,WANG Hui,XUE Fan,et al.Meta-analysis of the Effect of Valsartan Combined with Metformin in the Treatment of Obese Hypertension[J].Journal of Medical Information,2022,35(04):68.[doi:10.3969/j.issn.1006-1959.2022.15.014]
[3]房 芳,于 宏.利拉鲁肽联合二甲双胍治疗2型糖尿病的疗效观察[J].医学信息,2022,35(16):141.[doi:10.3969/j.issn.1006-1959.2022.16.036]
　FANG Fang,YU Hong.Effect of Liraglutide Combined with Metformin in the Treatment of Type 2 Diabetes Mellitus[J].Journal of Medical Information,2022,35(04):141.[doi:10.3969/j.issn.1006-1959.2022.16.036]
[4]苗 婷,刘子艳,刘玉媛,等.二甲双胍药理作用及其机制研究[J].医学信息,2019,32(14):53.[doi:10.3969/j.issn.1006-1959.2019.14.018]
　MIAO Ting,LIU Zi-yan,LIU Yu-yuan,et al.Study on Pharmacological Action and Mechanism of Metformin[J].Journal of Medical Information,2019,32(04):53.[doi:10.3969/j.issn.1006-1959.2019.14.018]
[5]金 川,张 颖,李瑞环,等.葛根芩连汤对2型糖尿病患者糖脂代谢指标及 体重的影响[J].医学信息,2019,32(14):164.[doi:10.3969/j.issn.1006-1959.2019.14.055]
　JIN Chuan,ZHANG Ying,LI Rui-huan,et al.Effect of Gegen Qinlian Decoction on Glucose and Lipid Metabolism Index and Body Weight in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2019,32(04):164.[doi:10.3969/j.issn.1006-1959.2019.14.055]
[6]尤 丽,卢 琦.甘精胰岛素联合二甲双胍治疗2型糖尿病的疗效[J].医学信息,2020,33(02):151.[doi:10.3969/j.issn.1006-1959.2020.02.046]
　YOU Li,LU Qi.Effect of Insulin Glargine Combined with Metformin in the Treatment of Type 2 Diabetes[J].Journal of Medical Information,2020,33(04):151.[doi:10.3969/j.issn.1006-1959.2020.02.046]
[7]王海燕,毕雪玲,曹 晶,等.坤泰胶囊联合炔雌醇环丙孕酮片、二甲双胍治疗多囊卵巢综合征的效果及对性激素的影响[J].医学信息,2020,33(20):129.[doi:10.3969/j.issn.1006-1959.2020.20.039]
　WANG Hai-yan,BI Xue-ling,CAO Jing,et al.The Effect of Kuntai Capsule Combined with Ethinyl Estradiol and Cyproterone Tablets and Metformin in the Treatment of Polycystic Ovary Syndrome and Its Influence on Sex Hormones[J].Journal of Medical Information,2020,33(04):129.[doi:10.3969/j.issn.1006-1959.2020.20.039]
[8]孙 铎,张秀珍,邓晓君.不同剂量二甲双胍联合磷酸西格列汀治疗2型糖尿病患者的临床疗效及安全性观察[J].医学信息,2023,36(09):135.[doi:10.3969/j.issn.1006-1959.2023.09.028]
　SUN Duo,ZHANG Xiu-zhen,DENG Xiao-jun.Clinical Efficacy and Safety of Different Doses of Metformin Combined with Sitagliptin Phosphate in the Treatment of Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2023,36(04):135.[doi:10.3969/j.issn.1006-1959.2023.09.028]
[9]杨晓旭,赵振宇.亚莫利联合二甲双胍对2型糖尿病的降糖效果观察[J].医学信息,2023,36(10):134.[doi:10.3969/j.issn.1006-1959.2023.10.029]
　YANG Xiao-xu,ZHAO Zhen-yu.Observation on Hypoglycemic Effect of Amaryl Combined with Metformin on Type 2 Diabetes Mellitus[J].Journal of Medical Information,2023,36(04):134.[doi:10.3969/j.issn.1006-1959.2023.10.029]
[10]张月田,刘世平.二甲双胍治疗2型糖尿病的不良反应及联合用药的应用[J].医学信息,2021,34(06):64.[doi:10.3969/j.issn.1006-1959.2021.06.017]
　ZHANG Yue-tian,LIU Shi-ping.Adverse Reactions of Metformin in the Treatment of Type 2 Diabetes and the Application of Combined Medication[J].Journal of Medical Information,2021,34(04):64.[doi:10.3969/j.issn.1006-1959.2021.06.017]

更新日期/Last Update: 2019-03-07